Latest News-SHANGHAI PHARMATECHS CO.LTD Mediaroom_Page

WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation

SINGAPORE, July 19, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufact...

2022-07-19 17:59 4351

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

Site Enhances New Modality CRDMO Platform Capacity for Customers SHANGHAI , July 6, 2022 /PRNewswir...

2022-07-07 08:00 3784

WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility

WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies

PHILADELPHIA and ST. LOUIS, MO and SAN DIEGO, June 15, 2022 /PRNewswire/ -- WuXi Advanced Therapies...

2022-06-16 08:00 1933

WuXi AppTec Reports Record First-Quarter In 2022

Revenue Up 71.2% Year-Over-Year to RMB8,474 Million Net Profit Attributable to Owners of the Compa...

2022-04-25 17:52 2749

WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics

SHANGHAI, April 7, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufactu...

2022-04-08 08:00 1911

WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics

WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

PHILADELPHIA, March 7, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subs...

2022-03-08 08:00 1530

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

SHANGHAI, Feb. 10, 2022 /PRNewswire/ -- WuXi STA, a subsidiary of WuXi AppTec, today announced that...

2022-02-11 10:00 1792

WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories

Statement by WuXi AppTec Regarding Recent Market Fluctuation

SHANGHAI, Dec. 15, 2021 /PRNewswire/ -- Our company's activities continue apace and we remain confi...

2021-12-16 08:00 2487

WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan

SHANGHAI, Dec. 8, 2021 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufactur...

2021-12-09 08:00 2115

WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers

PHILADELPHIA, Oct. 17, 2021 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a wholly owne...

2021-10-18 11:05 1721

WuXi AppTec Receives AA ESG Rating from MSCI

SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Mor...

2021-09-06 08:00 2517

WuXi AppTec Receives AA ESG Rating from MSCI

WuXi AppTec Reports Strong 2021 Interim Results

* Revenue Up 45.7% Year-Over-Year to RMB10,537 Million * Net Profit Attributable to Owners of th...

2021-08-12 17:52 3120

WuXi AppTec Reports Strong 2020 Annual Results

Revenue Up 28.5% Year-over-Year to RMB16,535 Million Net Profit Attributable to Owners of the Compan...

2021-03-30 21:10 3100

WuXi AppTec Recognized by Frost & Sullivan with 2020 Global Customer Value Leadership Award

SHANGHAI, Dec. 2, 2020 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufactur...

2020-12-03 08:00 1914

ViGeneron and WuXi Advanced Therapies Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

PHILADELPHIA and MUNICH, Dec. 1, 2020 /PRNewswire/ -- ViGeneron, a gene therapy company, and WuXi A...

2020-12-01 21:00 2896

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business un...

2020-11-18 21:00 1705

WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations

WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attribu...

2020-08-13 16:49 5120

WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia

SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they a...

2020-07-09 16:32 1600

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Devel...

2020-05-18 21:00 1994

WuXi AppTec Reports Solid First-Quarter 2020 Results

SHANGHAI, April 29, 2020 /PRNewswire/ -- WuXi AppTec Co., Ltd. (stock code: 603259.SH / 2359.HK), a...

2020-04-29 17:30 9124